Pharma Journalist 8922 posts 0 comments

The U.S. government has purchased 650,000 additional doses of Eli Lilly and Company's (NYSE: LLY) neutralizing antibody bamlanivimab (LY-CoV555) 700 mg. The purchase agreement is for…
Read More...

Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced the acquisition of rights to Hemera Biosciences, LLC's investigational…
Read More...

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the WaveWriter Alpha portfolio of Spinal Cord Stimulator (SCS) Systems. The portfolio, consisting of…
Read More...

Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics,  announced that its partner, BeiGene, Ltd., has dosed the first patient in South…
Read More...

Dr. Reddy’s Laboratories Ltd. and Russian Direct Investment Fund (RDIF) announced that they have commenced adaptive phase 2/3 clinical trials for Sputnik V vaccine in India after…
Read More...

atbtherapeutics, a pioneering biopharmaceutical company building an oncology pipeline using its antibody–toxin-bioengineered “atbody”, announces that it has entered a long-term…
Read More...

Tubulis, WuXi STA and WuXi Biologics announced a strategic collaboration to manufacture and advance Tubulis' next generation antibody-drug conjugates (ADCs) towards IND-enabling…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the add-on…
Read More...

CHO Plus, an early-stage innovation company developing technology to vastly increase the productivity of cells used to manufacture therapeutic proteins, announced that it has entered…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply…
Read More...